Innate Autoimmunity

Aderem, 1999, Mechanism of phagocytosis in macrophages, Annu. Rev. Immunol., 17, 593, 10.1146/annurev.immunol.17.1.593 Arumugam, 2003, A small molecule C5a receptor antagonist protects kidneys from ischemia–reperfusion injury in rats, Kidney Int., 63, 134, 10.1046/j.1523-1755.2003.00737.x Barton, 2003, Toll-like receptor signaling pathways, Science, 300, 1524, 10.1126/science.1085536 Baumgarth, 2000, B1 and B2 cell-derived immunoglobulin M antibodies are non-redundant components of the protective response to influenza virus infection, J. Exp. Med., 192, 271, 10.1084/jem.192.2.271 Boes, 1998, A critical role of natural IgM in immediate response against systemic bacterial infection, J. Exp. Med., 188, 2381, 10.1084/jem.188.12.2381 Briaud, 2001, Leukocyte trafficking and myocardial reperfusion injury in ICAM-1⧸P-selectin-knockout mice, Am. J. Physiol. Heart Circ. Physiol., 280, H60, 10.1152/ajpheart.2001.280.1.H60 Carroll, 1998, The role of complement and complement receptors in induction and regulation of immunity, Annu. Rev. Immunol., 16, 545, 10.1146/annurev.immunol.16.1.545 Cauchetaux, 2003, At the innate frontiers between mother and fetus: Linking abortion with complement activation, Immunity, 18, 169, 10.1016/S1074-7613(03)00028-1 Chai, 2000, Soluble complement receptor-1 protects heart, lung, and cardiac myofilament function from cardiopulmonary bypass damage, Circulation, 101, 541, 10.1161/01.CIR.101.5.541 Cotran, 1994 de Vries, 2003, Complement factor C5a mediates renal ischemia–reperfusion injury independent from neutrophils, J. Immunol., 170, 3883, 10.4049/jimmunol.170.7.3883 de Vries, 2003, Inhibition of complement factor 5 protects against renal ischemia–reperfusion injury: Inhibition of late apoptosis and inflammation, Transplantation, 75, 375, 10.1097/01.TP.0000044455.05584.2A Epstein, 1996, The collectins in innate immunity, Curr. Opin. Immunol., 8, 29, 10.1016/S0952-7915(96)80101-4 Espinosa, 2003, Antiphospholipid syndrome: Pathogenic mechanisms, Autoimmun. Rev., 2, 86, 10.1016/S1568-9972(02)00144-1 Fearon, 1995, The CD19⧸CR2⧸TAPA-1 Complex of B lymphocytes: Linking natural to acquired immunity, Annu. Rev. Immunol., 13, 127, 10.1146/annurev.iy.13.040195.001015 Fleming, 2002, Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire, J. Immunol., 169, 2126, 10.4049/jimmunol.169.4.2126 Foley, 1993, Mouse Crry⧸p65 is a regulator of the alternative pathway of complement activation, Eur. J. Immunol., 23, 1381, 10.1002/eji.1830230630 Girardi, 2003, Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome, J. Clin. Invest., 112, 1644, 10.1172/JCI200318817 Hannan, 2002, Structure of complement receptor (CR) 2 and CR2–C3d complexes, Biochem. Soc. Trans., 30, 983, 10.1042/bst0300983 Hardy, 1994, Distinctive developmental origins and specificities of murine CD5+ B cells, Immunol. Rev., 137, 91, 10.1111/j.1600-065X.1994.tb00660.x Hill, 1992, Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia–reperfusion in the rat, J. Immunol., 149, 1723, 10.4049/jimmunol.149.5.1723 Holers, 2001, Complement, 21.1, 218 Holers, 2002, Complement C3 activation is required for antiphospholipid antibody-induced fetal loss, J. Exp. Med., 195, 211, 10.1084/jem.200116116 Huang, 1999, Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein, Science, 285, 595, 10.1126/science.285.5427.595 Ikematsu, 1998, Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB⧸c mice, Arth. Rheum., 41, 1026, 10.1002/1529-0131(199806)41:6<1026::AID-ART9>3.0.CO;2-1 Janeway, 1999, Lipoproteins take their toll on the host, Curr. Biol., 9, R879, 10.1016/S0960-9822(00)80073-1 Kantor, 1997, An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells, J. Immunol., 158, 1175, 10.4049/jimmunol.158.3.1175 Kim, 1995, Mouse complement regulatory protein Crry⧸p65 utilizes the specific mechanisms of both decay-accelerating factor and membrane cofactor protein, J. Exp. Med., 181, 151, 10.1084/jem.181.1.151 Levy, 1996, The effects of acute renal failure on mortality: A cohort analysis, JAMA, 275, 1489, 10.1001/jama.1996.03530430033035 Li, 1993, Mouse Crry⧸p65: Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF, J. Immunol., 151, 4295, 10.4049/jimmunol.151.8.4295 Li, 2002, Reactive species mechanisms of cellular hypoxia–reoxygenation injury, Am. J. Physiol. Cell Physiol., 282, C227, 10.1152/ajpcell.00112.2001 Liano, 1998, The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings: The madrid acute renal failure study group, Kidney Int., 66, S16 Linton, 1999, Complement activation and inhibition in experimental models of arthritis, Mol. Immunol., 36, 905, 10.1016/S0161-5890(99)00113-3 Liszewski, 1996, Control of the complement system, Adv. Immunol., 61, 201, 10.1016/S0065-2776(08)60868-8 Liu, 2003, Involvement of mitochondrial K+ release and cellular efflux in ischemic and apoptotic neuronal death, J. Neurochem., 86, 966, 10.1046/j.1471-4159.2003.01913.x Malynn, 1990, Biased expression of JH-proximal VH genes occurs in the newly generated repertoire of neonatal and adult mice, J. Exp. Med., 171, 843, 10.1084/jem.171.3.843 Mao, 2003, Negligible role of antibodies and C5 in pregnancy loss associated exclusively with C3-dependent mechanisms through complement alternative pathway, Immunity, 19, 813, 10.1016/S1074-7613(03)00321-2 Matsumoto, 1997, Abrogation of the alternative complement pathway by targeted deletion of murine factor B, Proc. Natl. Acad. Sci. USA, 94, 8720, 10.1073/pnas.94.16.8720 McIntyre, 2003, Antiphospholipid antibodies: Discovery, definitions, detection and disease, Prog. Lipid Res., 42, 176, 10.1016/S0163-7827(02)00048-6 Mellor, 2001, Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy, Nat. Immunol., 2, 64, 10.1038/83183 Miwa, 2001, Characterization of glycosylphosphatidylinositol-anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity, Immunology, 104, 207, 10.1046/j.1365-2567.2001.01280.x Mizuno, 2001, Membrane complement regulators protect against the development of type II collagen-induced arthritis in rats, Arthritis Rheum., 44, 2425, 10.1002/1529-0131(200110)44:10<2425::AID-ART407>3.0.CO;2-4 Molina, 1992, Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologs of human CR1, J. Exp. Med., 175, 121, 10.1084/jem.175.1.121 Muller-Eberhard, 1988, Molecular organization and function of the complement system, Annu. Rev. Biochem., 57, 321, 10.1146/annurev.bi.57.070188.001541 Nath, 1985, Pathophysiology of chronic tubulo-interstitial disease in rats: Interactions of dietary acid load, ammonia, and complement component C3, J. Clin. Invest., 76, 667, 10.1172/JCI112020 Nishimura, 1998, Paroxysmal nocturnal hemoglobinuria: Molecular pathogenesis and molecular therapeutic approaches, Hematopathol. Mol. Hematol., 36, 119 Ochsenbein, 1999, Control of early viral and bacterial distribution and disease by natural antibodies, Science, 286, 2156, 10.1126/science.286.5447.2156 Park, 2002, Injury in renal ischemia–reperfusion is independent from immunoglobulins and T lymphocytes, Am. J. Physiol. Renal Physiol., 282, F352, 10.1152/ajprenal.00160.2001 Qin, 2001, Genomic structure, functional comparison, and tissue distribution of mouse Cd59a and Cd59b, Mamm. Genome, 12, 582, 10.1007/s00335-001-2060-8 Rand, 2000, Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: A thrombogenic mechanism for the antiphospholipid syndrome, J. Autoimmun., 15, 107, 10.1006/jaut.2000.0410 Ratnoff, 1983, The role of antibody in the activation of the alternative complement pathway, Springer Semm. Immunopathol., 6, 361, 10.1007/BF02116280 Reid, 1981, The proteolytic activation systems of complement, Annu. Rev. Biochem., 50, 433, 10.1146/annurev.bi.50.070181.002245 Reid, 2002, Functional activity of natural antibody is altered in Cr2-deficient mice, J. Immunol., 169, 5433, 10.4049/jimmunol.169.10.5433 Richards, 2002, The genetics and pathogenesis of haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura, Curr. Opin. Nephrol. Hypertens., 11, 431, 10.1097/00041552-200207000-00010 Richards, 2003, Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome, Proc. Natl. Acad. Sci. USA, 100, 12966, 10.1073/pnas.2135497100 Seidl, 1999, Predominant VH genes expressed in innate antibodies are associated with distinctive antigen-binding sites, Proc. Natl. Acad. Sci. USA, 96, 2262, 10.1073/pnas.96.5.2262 Sheridan, 2000, Pathophysiology of ischemic acute renal failure, Contrib. Nephrol., 132, 7, 10.1159/000060075 Simpson, 1993, Neutrophil and nonneutrophil-mediated injury in intestinal ischemia–reperfusion, Ann. Surg., 218, 444, 10.1097/00000658-199310000-00005 Sporer, 1981, Inefficacy of bicarbonate infusions on the course of postischaemic acute renal failure in the rat, Eur. J. Clin. Invest., 11, 311, 10.1111/j.1365-2362.1981.tb02122.x Stahl, 2003, Role for the alternative complement pathway in ischemia⧸reperfusion injury, Am. J. Pathol., 162, 449, 10.1016/S0002-9440(10)63839-4 Tatsumi, 2003, Intracellular ATP is required for mitochondrial apoptotic pathways in isolated hypoxic rat cardiac myocytes, Cardiovasc. Res., 59, 428, 10.1016/S0008-6363(03)00391-2 Thadhani, 1996, Acute renal failure, N. Engl. J. Med., 334, 1448, 10.1056/NEJM199605303342207 Thurman, 2003, Lack of a functional alternative pathway ameliorates ischemic acute renal failure in mice, J. Immunol., 170, 1517, 10.4049/jimmunol.170.3.1517 Thurman, 2005, A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice, Mol. Immunol., 42, 87, 10.1016/j.molimm.2004.07.043 Vabulas, 2002, HSP70 as endogenous stimulus of the Toll⧸interleukin-1 receptor signal pathway, J. Biol. Chem., 277, 15107, 10.1074/jbc.M111204200 Weiser, 1996, Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement, J. Exp. Med., 183, 2343, 10.1084/jem.183.5.2343 Weisman, 1990, Souble human complement receptor type I: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis, Science, 249, 146, 10.1126/science.2371562 Williams, 1999, Intestinal reperfusion injury is mediated by IgM and complement, J. Appl. Physiol., 86, 938, 10.1152/jappl.1999.86.3.938 Xu, 2000, A critical role for murine complement regulator Crry in fetomaternal tolerance, Science, 99, 498, 10.1126/science.287.5452.498 Zhang, 2004, Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia⧸reperfusion injury, Proc. Natl. Acad. Sci. USA, 101, 3886, 10.1073/pnas.0400347101 Zhou, 2000, Predominant role for C5b-9 in renal ischemia⧸reperfusion injury, J. Clin. Invest., 105, 1363, 10.1172/JCI8621